COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-01964-0001-0000-3
Chemical Name: Decabromodiphenyl oxide
CASRN: 1163-19-5
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 856353_SCE
Study Result: Negative

Study Result: Negative
Activation Trial Trial Call
No Activation  Negative 
No Activation  Negative 
Induced Rat Liver S9  1_S9  Negative 
Induced Rat Liver S9  2_S9  Negative 

Trial #: 1    Activation: No Activation    Date: 06/26/1984    Trial Call: Negative   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Dimethyl Sulfoxide
0         
50 1052 463 0.440 9.26 26.0 0.000
Negative (Not Specified)
0         
50 1046 476 0.455 9.52 26.0 3.397
Test Chemical Decabromodiphenyl oxide
 0.05      
50 1049 507 0.483 10.14 26.0 9.816
 0.16      
50 1047 459 0.438 9.18 26.0 -0.391
 0.5       
50 1050 472 0.450 9.44 26.0 2.138
16         
50 1050 489 0.466 9.78 26.0 5.817
50         
50 1051 454 0.432 9.08 26.0 -1.851
160         
50 1040 478 0.460 9.56 26.0 4.431
500         
25 518 197 0.380 7.88 26.0 -13.589
Positive Control Mitomycin-C
 0.0E-4    
50 1049 853 0.813 17.06 26.0 84.760
Mitomycin-C
 0.01      
10 209 619 2.962 61.90 26.0 572.944
Trend: -1.055        
Probability: 0.854        

Trial #: 2    Activation: No Activation    Date: 07/31/1984    Trial Call: Negative   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Dimethyl Sulfoxide
0         
50 1041 425 0.408 8.50 26.5 0.000
Test Chemical Decabromodiphenyl oxide
50         
50 1040 405 0.389 8.10 26.5 -4.614
100         
50 1043 397 0.381 7.94 26.5 -6.767
250         
50 1046 406 0.388 8.12 26.5 -4.927
500         
50 1044 380 0.364 7.60 26.5 -10.845
Positive Control Mitomycin-C
 0.0E-4    
50 1044 557 0.534 11.14 26.5 30.682
Mitomycin-C
 0.01      
10 210 490 2.333 49.00 26.5 471.529
Trend: -1.448        
Probability: 0.926        

Trial #: 1_S9    Activation: Induced Rat Liver S9    Date: 06/26/1984    Trial Call: Negative   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Negative (Not Specified)
0         
50 1042 435 0.417 8.70 26.0 7.777
Dimethyl Sulfoxide
0         
50 1043 404 0.387 8.08 26.0 0.000
Test Chemical Decabromodiphenyl oxide
 0.5       
50 1048 412 0.393 8.24 26.0 1.494
16         
50 1035 396 0.383 7.92 26.0 -1.223
160         
50 1042 400 0.384 8.00 26.0 -0.895
500         
0 0 0 0.000 0.00 0.0 N/A
Positive Control Cyclophosphamide
 0.3       
50 1040 527 0.507 10.54 26.0 30.822
Cyclophosphamide
2         
10 207 220 1.063 22.00 26.0 174.382
Trend: -0.269        
Probability: 0.606        

Trial #: 2_S9    Activation: Induced Rat Liver S9    Date: 07/31/1984    Trial Call: Negative   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Dimethyl Sulfoxide
0         
50 1042 467 0.448 9.34 26.0 0.000
Test Chemical Decabromodiphenyl oxide
50         
50 1047 432 0.413 8.64 26.0 -7.936
100         
50 1048 463 0.442 9.26 26.0 -1.424
250         
50 1048 419 0.400 8.38 26.0 -10.792
500         
50 1046 441 0.422 8.82 26.0 -5.929
Positive Control Cyclophosphamide
 0.3       
50 1048 643 0.614 12.86 26.0 36.899
Cyclophosphamide
2         
10 210 356 1.695 35.60 26.0 278.252
Trend: -1.086        
Probability: 0.861